Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Causaly logo — Unlock R&D productivity with the most complete AI platform f...

Causaly

Unlock R&D productivity with the most complete AI platform for life sciences.

Founded 2018 United Kingdom London, United Kingdom 120 employees Series B Total: $82.30M Biotechnology, Pharmaceutical

General Information

Company Name Causaly
Founded Year 2018
Location United Kingdom London, United Kingdom +1
Employees 120
Industries Biotechnology, Pharmaceutical
Funding Stage Series B
Social

Get notified when Causaly moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 01, 2026

Causaly is hosting a session of the Causaly Dissected webinar on September 9th, featuring presentations by its Director of Scientific Affairs and Senior Scientific Solutions Consultant.

Major Customer Win Aug 28, 2026

Causaly has secured a customer win with an External Innovation Advisor at a Top 10 Pharma company, helping them accelerate scientific research and decision-making.

New Partnership Aug 18, 2026

Causaly announced an integration with Syneos Health, involving the adoption of Causaly's platform across scientific workflows, from protocol development to proposal work.

Get alerts when Causaly shows new signals

AI Insight

Bounce Watch AI
2 months ago

Causaly is exhibiting robust strategic momentum, underscored by the recent launch of its 'Scientific Workflows' product and a significant collaboration with Microsoft aimed at bridging scientific computation and interpretation. These developments, coupled with a major customer win demonstrating accelerated oncology target identification and industry recognition, highlight the company's continuous innovation and strengthening market position in AI-driven R&D for life sciences.

Signal Types
Product Launch Partnership Customer Acquisition Recognition Hiring
Strategic Labels
AI Platform Expansion Strategic Partnerships Market Traction
Next Move: Expansion
·
Impact: 9/10
·
Ideal For: Growth-stage AI/Life Sciences Investors

About Causaly

Causaly, founded in 2018 and headquartered in the United Kingdom, is positioned at the intersection of biotechnology and pharmaceutical industries. The company aims to redefine human discovery boundaries through its transformative AI technologies. With the slogan "Unlock R&D productivity with the most complete AI platform for life sciences," Causaly is a pivotal resource for modern Life Science research organizations, enhancing the discovery-to-development pipeline in drug development.

The company's most recent financing round, a $60.00M Series B investment secured on 1 July 2023, underscores its promising growth trajectory. The investment consortium includes renowned entities such as Visionaries Club, Index Ventures, Marathon Venture Capital, and European Bank for Reconstruction and Development, among others. This robust backing reflects strong confidence in Causaly's potential to expedite the launch of life-changing therapies through accelerated data analysis and application.

Taxonomy: AI Platform, Life Sciences, Drug Discovery, Biomedical Research, Natural Language Understanding, Knowledge Graphs, R&D Productivity, Decision-Making, Transformative AI, Research Acceleration, Laboratory Insights, Cognitive Amplification, Pharmaceuticals

Services & Products

AI-driven R&D Acceleration
Scientific Decision Support
Automated Scientific Workflows
Data Integration and Analysis
Research and Discovery Automation
Regulatory Submission Support

Target Customers

Pharmaceutical Companies Biotech Startups Research and Development Teams Clinical Researchers Data Scientists in Life Sciences Regulatory Compliance Teams

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 8
Investor Investor Investor Investor Investor
•••• •••• 		01 Jul 2023
Unknown •••••• - 01 Oct 2022
Series A •••••• 4
Investor Investor Investor
•••• •••• 		01 May 2021
Series A •••••• 3
Investor Investor
•••• •••• 		01 Nov 2019
Seed •••••• 5
Investor
•••• •••• 		01 Jul 2018

Latest News

View All
19 AI healthtechs to watch, according to VCs — Sifted
19 AI healthtechs to watch, according to VCs
Sifted Apr 05, 2024
Top 100 Rising European Startups for 2025 revealed — Businesscloud.co.uk
Top 100 Rising European Startups for 2025 revealed
Businesscloud.co.uk May 15, 2025

Causaly Alternatives & Competitors

View All Alternatives
Causaly vs
Dimensions
Dimensions United Kingdom

Dimensions accelerates global research discovery and interpretation.

22 employees
Data Analytics, Information Technology
Compare Causaly vs Dimensions
Causaly vs
Serologicals Corporation
Serologicals Corporation

Empowering research institutes and life sciences enterprises with innovative solutions in drug disco...

Biotechnology
Causaly vs
Canventa Life Sciences
Canventa Life Sciences United States

Giving Life to Research

39 employees
Also compare with: Causaly vs Indeemo Indeemo Causaly vs Life Science Strategy Group, LLC Life Science Strategy Group, LLC View all alternatives

FAQ About Causaly

Unlock R&D productivity with the most complete AI platform for life sciences.
Causaly was founded in 2018.
Causaly is headquartered in London, United Kingdom.
Causaly operates in the following industries: Biotechnology, Pharmaceutical.
Causaly has approximately 120 employees.
Causaly has completed 5 funding rounds, raising a total of $82.30M. The latest funding stage is Series B.
Causaly offers: AI-driven R&D Acceleration, Scientific Decision Support, Automated Scientific Workflows, Data Integration and Analysis, Research and Discovery Automation, Regulatory Submission Support.
Top alternatives and competitors to Causaly include Dimensions, Serologicals Corporation, Canventa Life Sciences , Indeemo, Life Science Strategy Group, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Causaly and Dimensions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Causaly and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy